• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 3.39% Nasdaq Down 4.12%

    Gilead Sciences Inc. (GILD)

    -NasdaqGS
    80.47 Down 2.90(3.48%) Jun 24, 4:00PM EDT
    |After Hours : 80.25 Down 0.22 (0.27%) Jun 24, 7:59PM EDT
    Prev Close:83.37
    Open:81.04
    Bid:80.21 x 100
    Ask:80.38 x 100
    1y Target Est:110.89
    Beta:1.23616
    Earnings Date:Jul 26 - Aug 1 (Est.)
    Day's Range:80.22 - 82.25
    52wk Range:80.22 - 120.37
    Volume:12,438,024
    Avg Vol (3m):9,684,000
    Market Cap:107.17B
    P/E (ttm):6.87
    EPS (ttm):11.71
    Div & Yield:1.88 (2.28%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    GILDDown 3.48%107.17B
    GSKDown 4.14%99.10B
    PFEDown 1.79%206.02B

    Key Statistics

    Forward P/E (1 yr):6.53
    P/S (ttm):3.38
    Ex-Dividend Date:14-Jun-16

    Analysts

    Annual EPS Est (Dec-16) :12.06
    Quarterly EPS Est (Jun-16) :2.99
    Mean Recommendation*:2.1
    PEG Ratio (5 yr expected):10.26

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Gilead Sciences, Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical needs in North America, South America, Europe, and the Asia-Pacific. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback